Daiichi, Apotex Settle Patent Suit Over Evoxac ANDA
Daiichi Sankyo Inc. has announced a settlement and licensing agreement in a patent infringement suit against Apotex Corp. that will allow the generic-drug maker to introduce its own version of Evoxac...To view the full article, register now.
Already a subscriber? Click here to view full article